Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$175K Buy
1,035
+3
+0.3% +$523 ﹤0.01% 669
2025
Q4
$168K Buy
1,032
+3
+0.3% +$451 ﹤0.01% 652
2025
Q3
$139K Sell
1,029
-82
-7% -$11.6K ﹤0.01% 659
2025
Q2
$144K Hold
1,111
﹤0.01% 593
2025
Q1
$134K Buy
+1,111
New +$143K 0.01% 581
2023
Q1
Sell
-300
Closed -$40K 1044
2022
Q4
$40K Hold
300
﹤0.01% 658
2022
Q3
$32K Hold
300
﹤0.01% 645
2022
Q2
$31K Hold
300
﹤0.01% 641
2022
Q1
$45K Hold
300
﹤0.01% 567
2021
Q4
$34K Buy
+300
New +$32.8K ﹤0.01% 628

Other funds holding NUE

Capital Analysts LLC's NUE Position: Q1 2026 in Review

Capital Analysts LLC increased its Nucor (NUE) stake by 0.29% in Q1 2026, buying an estimated $523 and bringing the position to 1,035 shares worth $175K. The position accounts for ﹤0.01% of the portfolio, ranked #669.

Capital Analysts LLC first reported a position in NUE in Q4 2021 and has held it in 10 quarters since. 1,371 funds tracked by Wall St. Rank hold NUE as of Q1 2026.

  • Capital Analysts LLC held 1,035 shares of Nucor worth $175K as of Q1 2026.
  • Capital Analysts LLC bought 3 Nucor shares in Q1 2026, an estimated $523.
  • Nucor made up ﹤0.01% of Capital Analysts LLC's portfolio in Q1 2026, its #669 holding.
  • Capital Analysts LLC first reported a position in Nucor in Q4 2021 and has held it in 10 quarters since.
  • 1,371 funds tracked by Wall St. Rank held Nucor as of Q1 2026.

Based on Capital Analysts LLC's 13F filing for Q1 2026, filed 14 May 2026.